← All Sponsors
SPONSOR

Avalyn Pharma Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Progressive Pulmonary Fibrosis
NCT06329401 Phase 2
Recruiting

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

Progressive Pulmonary Fibrosis
United States, Argentina, Australia View Trial →